GT
RPRX icon

Greenleaf Trust’s Royalty Pharma RPRX Stock Holding History

Greenleaf Trust’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Buy
+4,157
New +$216K ﹤0.01% 784
2022
Q3 		– Sell
-4,786
Closed -$201K – 736
2022
Q2 		$201K Buy
+4,786
New +$196K ﹤0.01% 674

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Greenleaf Trust's RPRX Position: Q2 2026 in Review

Greenleaf Trust opened a new position in Royalty Pharma (RPRX) in Q2 2026: 4,157 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #784 among its holdings. This is a return to the name: Greenleaf Trust previously reported a position in RPRX as recently as Q2 2022.

Greenleaf Trust first reported a position in RPRX in Q2 2022 and has held it in 2 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Greenleaf Trust held 4,157 shares of Royalty Pharma worth $233K as of Q2 2026.
  • Royalty Pharma was a new Greenleaf Trust position in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #784 holding.
  • Greenleaf Trust first reported a position in Royalty Pharma in Q2 2022 and has held it in 2 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.